Paper9740480
Valsartan in heart failure patients previously untreated with an ACE inhibitor.
Mazayev VP and 10 others. Int J Cardiol, 1998. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Valsartan in heart failure patients previously untreated with an ACE inhibitor. Papers, record 9740480. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9740480
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin Receptor Antagonists | Major topic |
| Antihypertensive Agents | Major topic |
| Heart Failure | Major topic |
| Tetrazoles | Major topic |
| Valine | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Analysis of Variance | |
| Angiotensin-Converting Enzyme Inhibitors | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Female | |
| Hemodynamics | |
| Humans | |
| Least-Squares Analysis | |
| Lisinopril | |
| Male | |
| Matched-Pair Analysis | |
| Middle Aged | |
| Renin-Angiotensin System | |
| Time Factors | |
| Valsartan |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36918917 | Arterial stiffness and its associations with left ventricular diastolic function according to heart failure types. | Clin Hypertens | 2023 | https://conductscience.org/library/papers/36918917 | PubMed |
| 34022072 | Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34022072 | PubMed |
| 29952095 | Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29952095 | PubMed |
| 26156887 | Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan. | Eur J Drug Metab Pharmacokinet | 2016 | https://conductscience.org/library/papers/26156887 | PubMed |
| 22513909 | Angiotensin receptor blockers for heart failure. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22513909 | PubMed |
| 12710864 | Cardiovascular drug therapy in the elderly: theoretical and practical considerations. | Drugs Aging | 2003 | https://conductscience.org/library/papers/12710864 | PubMed |
| 12093312 | Angiotensin II receptor antagonists in chronic heart failure: where do they fit? | Drugs | 2002 | https://conductscience.org/library/papers/12093312 | PubMed |
| 11714415 | Angiotensin receptor blockers in heart failure after the ELITE II trial. | Curr Control Trials Cardiovasc Med | 2000 | https://conductscience.org/library/papers/11714415 | PubMed |
| 11288962 | Angiotensin receptor blockers: evidence for preserving target organs. | Clin Cardiol | 2001 | https://conductscience.org/library/papers/11288962 | PubMed |
| 10981096 | Spectrum of use for the angiotensin-receptor blocking drugs. | Curr Hypertens Rep | 1999 | https://conductscience.org/library/papers/10981096 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9740480
GET https://conductscience.org/api/papers/v1/9740480/authors